Doliver Advisors’s Labcorp LH Stock Holding History

Doliver Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,594	Closed	-$349K	–	150
2021 Q1	$349K	Buy	+1,594	New	+$320K	0.13%	99

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Doliver Advisors's LH Position: Q2 2021 in Review

Doliver Advisors sold out of Labcorp (LH) in Q2 2021, closing a stake of 1,594 shares — an estimated $349K sold.

Doliver Advisors first reported a position in LH in Q1 2021 and held it in 1 quarter. The position peaked at $349K in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

Doliver Advisors reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
Doliver Advisors sold 1,594 Labcorp shares in Q2 2021, an estimated $349K.
Doliver Advisors first reported a position in Labcorp in Q1 2021 and held it in 1 quarter.
Doliver Advisors's Labcorp position peaked at $349K in Q1 2021.
948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on Doliver Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.